Brain scans of people with mild cognitive impairment show signs of early Alzheimer's disease

NewsGuard 100/100 Score

Brain scans of people with mild cognitive impairment (MCI) show signs of early Alzheimer's disease, according to a study published in the May 8, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

For the study, PET scans were performed on the brains of 13 elderly men and women with mild cognitive impairment (MCI) and 14 elderly people without memory problems. The scans were used to measure uptake of PIB, which is an imaging agent that allows doctors to see and measure abnormal protein aggregation growth, otherwise known as amyloid plaque, in the brain. Abnormal protein aggregation growth is a signature of Alzheimer's disease. Until recently, Alzheimer's disease couldn't be officially diagnosed until after death with an autopsy.

The study found people with MCI had as much as 39 percent more PIB uptake in some parts of the brain than people without MCI. And about half of the MCI patients had PIB uptake in the Alzheimer's disease range.

"This pattern of increased PIB in patients with MCI resembles what's seen in Alzheimer's disease and is suggestive of an early Alzheimer's disease process," said study author Juha O. Rinne, MD, PhD, with the University of Turku in Turku, Finland, and Fellow of the American Academy of Neurology. "Our findings are similar to what's seen in post-mortem studies in which abnormal protein aggregation growth is found in people who had been diagnosed with probable Alzheimer's disease."

Rinne says larger studies and extended follow-up is needed since identifying people with MCI who have abnormal protein aggregation growth will become increasingly important as treatments affecting such plaque amyloid accumulation become available.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough brain stimulator could revolutionize treatment for neurological disorders